| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.686 | 14.244 | 10.427 | 5.435 | 11.535 | 14.282 | 17.837 | 18.563 |
| Total Income - EUR | - | - | 1.686 | 14.244 | 10.427 | 5.435 | 11.613 | 14.282 | 17.837 | 18.641 |
| Total Expenses - EUR | - | - | 3.389 | 11.715 | 9.162 | 5.844 | 11.856 | 14.672 | 16.761 | 18.058 |
| Gross Profit/Loss - EUR | - | - | -1.703 | 2.528 | 1.265 | -409 | -243 | -390 | 1.076 | 582 |
| Net Profit/Loss - EUR | - | - | -1.720 | 2.386 | 1.160 | -460 | -356 | -530 | 898 | 26 |
| Employees | - | - | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Reflexo Tox S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.333 | 1.139 | 951 | 1.756 | 1.446 | 1.178 | 903 | 628 |
| Current Assets | - | - | 453 | 872 | 1.505 | 309 | 638 | 584 | 2.202 | 2.473 |
| Inventories | - | - | 43 | 79 | 0 | 0 | 16 | 128 | 138 | 1.088 |
| Receivables | - | - | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Cash | - | - | 300 | 686 | 1.400 | 205 | 521 | 355 | 1.964 | 1.285 |
| Shareholders Funds | - | - | -1.611 | 805 | 1.949 | 1.453 | 1.064 | 537 | 1.433 | 1.454 |
| Social Capital | - | - | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | - | 3.396 | 1.206 | 507 | 612 | 1.019 | 1.225 | 1.672 | 1.647 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Reflexo Tox S.r.l.